Used in pharmaceutical synthesis as a key chiral intermediate for developing bioactive molecules, particularly in the production of central nervous system agents. Its piperazine backbone with a hydroxymethyl group enables selective modifications for drug candidates targeting neurological disorders. Commonly employed in the development of serotonin and dopamine receptor modulators due to its favorable stereochemistry and solubility profile. Also utilized in medicinal chemistry research for structure-activity relationship studies of psychoactive compounds.